Review Article on Adrenergic Neurotransmitter

Here’s a potential introduction to adrenergic neurotransmitters:

Adrenergic neurotransmitters, also known as catecholamine’s, are a group of chemical messengers that play a crucial role in regulating various physiological responses in the body. The two primary adrenergic neurotransmitters are:

1. Epinephrine (Adrenaline)

2. Norepinephrine (Noradrenaline)

These neurotransmitters are released by the adrenal glands and sympathetic nerves in response to stress, excitement, or danger. They interact with adrenergic receptors in various tissues, including the heart, blood vessels, smooth muscle, and immune cells, to modulate physiological responses such as:

- Heart rate and blood pressure

- Energy metabolism and glucose release

- Smooth muscle contraction and relaxation

- Immune response and inflammation

Adrenergic neurotransmitters are essential for the body’s “fight or flight” response, preparing the body to respond to stress or danger. They also play a role in maintaining physiological homeostasis, regulating various bodily functions, and influencing behaviour and mood. Understanding adrenergic neurotransmitters is crucial for developing treatments for various diseases and disorders, such as hypertension, cardiovascular disease, asthma, and attention deficit hyperactivity disorder (ADHD). Adrenergic receptors are a class of G-protein coupled receptors that play a crucial role in mediating the physiological effects of adrenergic neurotransmitters, such as epinephrine (adrenaline) and norepinephrine (noradrenaline). These receptors are widely distributed throughout the body and are found in various tissues, including:

- Heart

- Blood vessels

- Smooth muscle

- Immune cells

- Brain

Adrenergic receptors are divided into two main subfamilies:

1. Alpha-adrenergic receptors (α1, α2).

2. Beta-adrenergic receptors (β1, β2, β3)

Each subfamily has distinct pharmacological and physiological properties, and they play specific roles in regulating various physiological responses, such as:

- Vasoconstriction and vasodilation

J- Heart rate and contractility

- Smooth muscle contraction and relaxation

- Energy metabolism and glucose release

- Immune response and inflammation

Adrenergic receptors are essential for maintaining physiological homeostasis and responding to stress, excitement, or danger. Dysregulation of adrenergic receptors has been implicated in various diseases and disorders, including:

- Hypertension

- Cardiovascular disease

- Asthma

- Attention deficit hyperactivity disorder (ADHD)

Understanding adrenergic receptors is crucial for developing targeted therapies for these diseases and for improving our understanding of the complex physiological processes they regulate. Naturally occur in our body.both agents that activate adrenergic receptors are called sympathomimetics the agents that block the activation of adrenergic receptors are called sympatholytics.

Adrenergic neurotransmitters are 3 types collectively called catecholamines:

1. Noradrenaline (NA)-at postganglionic sympathetic sites (except sweat glands, hair follicles) & in certain areas of brain.

2. Adrenaline (ADR) - secreted by adrenal medulla.

Dopamine(da)- transmitter in basal ganglia, limbic system, ctz, anterior pituitary

Fig.1.1 Synthesis and release of norepinephrine

1. 2-Biosynthesis of catecholamine

1. The process begins with the amino acid tyrosine, which is taken up from the bloodstream into the nerve terminal.
2. The enzyme tyrosine hydroxylase then converts tyrosine into DOPA (dihydroxyphenylalanine). This is the rate-limiting step, meaning it's the slowest step and thus determines the overall rate of catecholamine synthesis.
3. DOPA is then converted into dopamine by the enzyme DOPA decarboxylase.
4. If the neurotransmitter being produced is norepinephrine, dopamine is then taken up into storage vesicles, where the enzyme dopamine-beta-hydroxylase converts it into norepinephrine.
5. In some neurons, mostly located in the adrenal medulla, norepinephrine can be further converted into epinephrine by the enzyme phenylethanolamine N-methyltransferase.
6. bloodstream into the nerve terminal.

1.3 Catabolism of Catecholamine

Catabolism of Catecholamines

The breakdown, or catabolism, of catecholamines occurs through two main pathways involving specific enzymes:

1.The enzyme monoamine oxidase (MAO) is located in the mitochondria of the nerve terminal and catalyzes the oxidative deamination of the catecholamines. This enzyme breaks down dopamine, norepinephrine, and epinephrine into their respective aldehyde metabolites.

2.The catechol-O-methyltransferase (COMT) enzyme catalyzes the transfer of a methyl group to the catecholamines, creating a methylated metabolite.

The aldehyde metabolites can be further metabolized by aldehyde dehydrogenase to form corresponding acids or by aldehyde reductase to form glycols. For example, certain forms of depression and Parkinson's disease are associated with deficiencies in catecholamine neurotransmitters, while certain forms of mania and schizophrenia are associated with an overactivity of catecholaminergic systems.

Adrenergic Receptors

The adrenergic receptors or adrenoceptors are a class of G protein-coupled receptors that are targets of many catecholamines like norepinephrine (noradrenaline) and epinephrine (adrenaline) produced by the body, but also many medications like beta blockers, beta-2 (β2) agonists and alpha-2 (α2) agonists, which are used to treat high blood pressure and asthma, for example.

Classification